Otomycosis in Western Iran: Clinical and Mycological Aspects

Authors Information
Article Notes and Dates
To Cite : Cheraghsahar S, Kazemi S, Birjandi M, Yarahmadi M, Mahmoudi S, et al. Otomycosis in Western Iran: Clinical and Mycological Aspects, Arch Clin Infect Dis. 2017 ;12(2):e57287. doi: 10.5812/archcid.57287.
Copyright: Copyright © 2017, Archives of Clinical Infectious Diseases. .
Abstract
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Nemati S, Hassanzadeh R, Khajeh Jahromi S, Delkhosh Nasrollah Abadi A. Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents. Eur Arch Otorhinolaryngol. 2014; 271(5): 953-7[DOI][PubMed]
  • 2. Saki N, Rafiei A, Nikakhlagh S, Amirrajab N, Saki S. Prevalence of otomycosis in Khouzestan Province, south-west Iran. J Laryngol Otol. 2013; 127(1): 25-7[DOI][PubMed]
  • 3. Gharaghani M, Seifi Z, Zarei Mahmoudabadi A. Otomycosis in iran: a review. Mycopathologia. 2015; 179(5-6): 415-24[DOI][PubMed]
  • 4. Barati B, Okhovvat SA, Goljanian A, Omrani MR. Otomycosis in central iran: a clinical and mycological study. Iran Red Crescent Med J. 2011; 13(12): 873-6[PubMed]
  • 5. Jia X, Liang Q, Chi F, Cao W. Otomycosis in Shanghai: aetiology, clinical features and therapy. Mycoses. 2012; 55(5): 404-9[DOI][PubMed]
  • 6. Fasunla J, Ibekwe T, Onakoya P. Otomycosis in western Nigeria. Mycoses. 2008; 51(1): 67-70[DOI][PubMed]
  • 7. Vennewald I, Klemm E. Otomycosis: Diagnosis and treatment. Clin Dermatol. 2010; 28(2): 202-11[DOI][PubMed]
  • 8. Bineshian F, Irajian G, Koochak-Alavi SK, Fredonian MR. A study on the frequency of fungal agents in otitis externa in Semnan. Iran J Pathol. 2006; 1(4): 141-4
  • 9. Pradhan B, Tuladhar NR, Amatya RM. Prevalence of otomycosis in outpatient department of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal. Ann Otol Rhinol Laryngol. 2003; 112(4): 384-7[DOI][PubMed]
  • 10. Ho T, Vrabec JT, Yoo D, Coker NJ. Otomycosis: clinical features and treatment implications. Otolaryngol Head Neck Surg. 2006; 135(5): 787-91[DOI][PubMed]
  • 11. Kazemi A, Majidinia M, Jaafari A, Ayatollahi Mousavi SA, Zarei Mahmoudabadi A, Alikhah H. Etiologic Agents of Otomycosis in the North-Western Area of Iran. Jundishapur J Microbiol. 2015; 8(9)[DOI][PubMed]
  • 12. Desai KJ, Malek SS, Italia IK, Jha S, Pandya V, Shah H. Fungal spectrum in otomycosis at tertiary care hospital. Natl J Integr Res Med. 2012; 3(5)
  • 13. Song JE, Haberkamp TJ, Patel R, Redleaf MI. Fungal otitis externa as a cause of tympanic membrane perforation: a case series. Ear Nose Throat J. 2014; 93(8): 332-6[PubMed]
  • 14. Kiakojuri K, Rajabnia R, Jalili B, Khafri S, Omran SM. Otomycosis in Adolescent Patients Referred to the Therapeutic Centers in Babol City, Iran. Jundishapur J Microbiol. 2015; 8(5)[DOI][PubMed]
  • 15. Nowrozi H, Doustdar Arabi F, Ghaffarnejad Mehraban H, Tavakoli A, Ghooshchi G. Mycological and clinical study of otomycosis in Tehran, Iran. Bull Environ Pharmacol Life Sci. 2014; 3(2): 29-31
  • 16. Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol. 2008; 72(4): 453-9[DOI][PubMed]
  • 17. Abdelazeem M, Gamea A, Mubarak H, Elzawawy N. Epidemiology, causative agents, and risk factors affecting human otomycosis infections. Turk J Med Sci. 2015; 45(4): 820-6[DOI][PubMed]
  • 18. Bhan C, Purohit K, Prasad Purohit J, Kumar V, Singh Yadav H. Clinical vs bacteriological and mycological evaluation in chronic suppurative otitis media. Int J Contemp Med Res. 2016; 3(5): 1443-7
  • 19. Pontes ZB, Silva AD, Lima Ede O, Guerra Mde H, Oliveira NM, Carvalho Mde F, et al. Otomycosis: a retrospective study. Braz J Otorhinolaryngol. 2009; 75(3): 367-70[DOI][PubMed]
  • 20. Ibiam F, Adekwu A, Obasikene G, Ezeanolue B, Okoroafor I, Iroezindu M. Aetiological agents implicated in otitis externa-an update. PMJUMU. 2016; 5(9): 1-12
  • 21. Ozcan M, Ozcan KM, Karaarslan A, Karaarslan F. Concomitant otomycosis and dermatomycoses: a clinical and microbiological study. Eur Arch Otorhinolaryngol. 2003; 260(1): 24-7[DOI][PubMed]
  • 22. Arndal E, Glad H, Homoe P. Large discrepancies in otomycosis treatment in private ear, nose, and throat clinics in Denmark. Dan Med J. 2016; 63(5)[PubMed]
  • 23. Kurnatowski P, Filipiak J. Otitis externa: the analysis of relationship between particular signs/symptoms and species and genera of identified microorganisms. Wiad Parazytol. 2008; 54(1): 37-41[PubMed]
  • 24. Rutt AL, Sataloff RT. Aspergillus otomycosis in an immunocompromised patient. Ear Nose Throat J. 2008; 87(11): 622-3[PubMed]
  • 25. Szigeti G, Sedaghati E, Mahmoudabadi AZ, Naseri A, Kocsube S, Vagvolgyi C, et al. Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran. Mycoses. 2012; 55(4): 333-8[DOI][PubMed]
  • 26. Kaya AD, Kiraz N. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole. Mycoses. 2007; 50(6): 447-50[DOI][PubMed]
  • 27. Szigeti G, Kocsube S, Doczi I, Bereczki L, Vagvolgyi C, Varga J. Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary. Mycopathologia. 2012; 174(2): 143-7[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Archives of Clinical Infectious Diseases accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check